Black Diamond Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD | — | Other | 5,176 | — | — | 5,176 | Aug 12, 2020 |
| Versant Voyageurs I Parallel, L.P. | — | Sale | 6,692 | $33.08 | $221,371 | 6,797,230 | Aug 11, 2020 |
| Bolzon Bradley J PhD | — | Sale | 5,492 | $33.04 | $181,456 | 6,803,922 | Aug 11, 2020 |
| Versant Voyageurs I Parallel, L.P. | — | Other | 4,131 | — | — | — | Jul 27, 2020 |
| Bolzon Bradley J PhD | — | Other | 192,576 | — | — | 2,017,016 | Jul 27, 2020 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | — | C | 568,185 | — | — | 568,185 | Feb 3, 2020 |
| Versant Venture Capital VI, L.P. | — | C | 104,407 | — | — | 635,309 | Feb 3, 2020 |
| Bolzon Bradley J PhD | — | C | 4,973,787 | — | — | 5,305,372 | Feb 3, 2020 |
| Shah Rajeev M. | — | C | 186,749 | — | — | 186,749 | Feb 3, 2020 |
| Epstein David M. | See Remarks | C | 4,354 | — | — | 729,923 | Feb 3, 2020 |
| Menzel Garry E | — | C | 51,825 | — | — | 51,825 | Feb 3, 2020 |
| Hatzis-Schoch Brent | See Remarks | Purchase | 3,000 | $19.00 | $57,000 | 3,000 | Feb 3, 2020 |
| Behbahani Ali | — | C | 471,800 | — | — | 2,648,757 | Feb 3, 2020 |
| DEERFIELD PARTNERS, L.P. | — | Purchase | 400,000 | $19.00 | $7,600,000 | 778,790 | Feb 3, 2020 |